Cholesterol Wonder Drugs Statins can also Prevent Cancer: Study

Statin-takers are less likely to die from cancer suggests a new study.

Enzyme-inhibiting drugs known as statins have been widely used to lower cholesterol for decades.

Statins reduce risks for angioplasty patients
Cholesterol-lowering drugs that help prevent heart disease also appear to cut the risk of a heart attack and other complications after angioplasty.

Now, the new study suggests that they may offer other benefits beyond their typical use, CBS News reported.

Currently, statins are primarily prescribed to control cholesterol, and are typically prescribed if your total cholesterol is 240 or above, or if your LDL (a.k.a. "bad" cholesterol) is over 130. Some commonly prescribed statins are Crestor, Lipitor and Zocor.

The new study indicates that the drugs were safer than originally thought.

Long-Term Benefits Of Statins Questioned
Researchers say that they have now found out that long-term use of statins may decrease mortality rates and even the incidence of

Researchers who looked at data from more than 250,000 people found that the drugs are safe.

Statins not only lower cholesterol, but research has shown that they can also decrease inflammation throughout the body, which leads many physicians to argue that statins can be used to treat problems associated with it.

Statins Control Blood Pressure too
A new study finds that statins used for busting cholesterol also control hypertension

Statins' heart benefits outweigh diabetes risk in pill-takers, study has shown.

In addition to lowering cholesterol, statins lower inflammation in the body, particularly in the blood vessels.

Further support for use of statins in Alzheimer�s disease
People who take the cholesterol-lowering drugs called statins may reduce their risk of developing Alzheimer's disease by nearly 80%. Statins have

Inflammation is linked to a number of other diseases: Alzheimer's disease, a number of forms of cancer, strokes.

The drugs could also cause muscle pain or damage, nausea, headaches, or elevated liver enzymes.

The findings are published in the journal Circulation: Cardiovascular Quality and Outcomes.

Source-ANI